rosiglitazone has been researched along with Cancer of Granulosa Cells in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, S; Fuller, PJ; Leung, DTH; Nguyen, T; Rainczuk, A; Silke, J; Stephens, A | 1 |
1 other study(ies) available for rosiglitazone and Cancer of Granulosa Cells
| Article | Year |
|---|---|
Targeting XIAP and PPARĪ³ in Granulosa Cell Tumors Alters Metabolic Signaling.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Female; Granulosa Cell Tumor; Humans; PPAR gamma; Proteome; Proteomics; Rosiglitazone; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein | 2019 |